{
    "eid": "2-s2.0-85125504794",
    "title": "Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study",
    "cover-date": "2022-02-15",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "anti-epidermal growth factor receptor (EGFR) antibodies",
        "later-line treatment",
        "metastatic colorectal cancer",
        "primary tumor location",
        "sidedness"
    ],
    "authors": [
        "Anita Archwamety",
        "Nattaya Teeyapun",
        "Teerada Siripoon",
        "Naravat Poungvarin",
        "Suebpong Tanasanvimon",
        "Ekaphop Sirachainan",
        "Charuwan Akewanlop",
        "Krittiya Korphaisarn"
    ],
    "citedby-count": 1,
    "ref-count": 25,
    "ref-list": [
        "Effect of First\u2013Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild\u2013Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial",
        "Extended RAS Analysis for Anti\u2013Epidermal Growth Factor Therapy in Patients With Metastatic Colorectal Cancer",
        "Final Analysis of the Randomised PEAK Trial: Overall Survival and Tumour Responses During First\u2013Line Treatment With Mfolfox6 Plus Either Panitumumab or Bevacizumab in Patients With Metastatic Colorectal Carcinoma",
        "FOLFIRI Plus Cetuximab Versus FOLFIRI Plus Bevacizumab as First\u2013Line Treatment for Patients With Metastatic Colorectal Cancer (FIRE\u20133): A Randomised, Open\u2013Label, Phase 3 Trial",
        "Primary Tumor Sidedness Has an Impact on Prognosis and Treatment Outcome in Metastatic Colorectal Cancer: Results From Two Randomized First\u2013Line Panitumumab Studies",
        "ESMO Consensus Guidelines for the Management of Patients With Metastatic Colorectal Cancer",
        "AJCC 8th Edition: Colorectal Cancer",
        "Distal and Proximal Colon Cancers Differ in Terms of Molecular, Pathological, and Clinical Features",
        "Colorectal Cancer Incidence Trends in the United States and United Kingdom: Evidence of Right\u2013 to Left\u2013Sided Biological Gradients With Implications for Screening",
        "Impact of Primary Tumor Location on Overall Suvival (OS) and Progression\u2013Free Survival (PFS) in Patients (Pts) With Metastatic Colorectal Cancer (Mcrc): Analysis of CALGB/SWOG 80405 (Alliance)",
        "Prognostic and Predictive Value of Primary Tumour Side in Patients With RAS Wild\u2013Type Metastatic Colorectal Cancer Treated With Chemotherapy and EGFR Directed Antibodies in Six Randomized Trials",
        "Prognostic Survival Associated With Left\u2013Sided vs Right\u2013Sided Colon Cancer: A Systematic Review and Meta\u2013Analysis",
        "The Relevance of Primary Tumour Location in Patients With Metastatic Colorectal Cancer: A Meta\u2013Analysis of First\u2013Line Clinical Trials",
        "Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer",
        "Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone as First\u2013Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study",
        "PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (Mfolfox6) or Bevacizumab Plus Mfolfox6 in Patients With Previously Untreated, Unresectable, Wild\u2013Type KRAS Exon 2 Metastatic Colorectal Cancer",
        "Effect of Primary Tumor Location on Second\u2013 or Later\u2013Line Treatment Outcomes in Patients With RAS Wild\u2013Type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies",
        "Final Results From a Randomized Phase 3 Study of FOLFIRI {+/\u2013} Panitumumab for Second\u2013Line Treatment of Metastatic Colorectal Cancer",
        "A Phase 3 Trial Evaluating Panitumumab Plus Best Supportive Care vs Best Supportive Care in Chemorefractory Wild\u2013Type KRAS or RAS Metastatic Colorectal Cancer",
        "Regorafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer (CORRECT): An International, Multicentre, Randomised, Placebo\u2013Controlled, Phase 3 Trial",
        "Regorafenib Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Asian Patients With Previously Treated Metastatic Colorectal Cancer (CONCUR): A Randomised, Double\u2013Blind, Placebo\u2013Controlled, Phase 3 Trial",
        "Results of a Randomized, Double\u2013Blind, Placebo\u2013Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS\u2013102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study",
        "Randomized Trial of TAS\u2013102 for Refractory Metastatic Colorectal Cancer"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}